Nutraceuticals
A tested Selective Serotonin Re-uptake Inhibitor (SSRI) that contributes to emotional balance (Crocus sativus L., Saffron)


Mechanism of Action
Serotonin (5HT) is a neurotransmitter that influences mood behaviour.
Releasing more serotonin in the brain induces mood well-being in most depressed subjects.
In the majority of depressed people, Serotonin is re-uptaked the most after its release, barely delivering its effects.
Inhibiting serotonin re-uptake by Selective Serotonin Re-uptake Inhibitors (SSRI) as Imipramine (TOFRANIL®) and Fluoxetine (PROZAC®) is a key mechanism of action to relieve depression in modern medicine.
Non depressed
Serotonin is:
- Released
- Reuptaked SLIGHTLY
- Binding its receptors
- Making effect
Depressed
Serotonin is:
- Released
- Reuptaked MOSTLY
- No binding its receptors
- No making effect
Depressed SSRI treatment
Serotonin is:
- Released
- Reuptake IS INHIBITED
- Binding its receptors
- Making effects

In Vitro Study
- The purpose of this study was to investigate the mechanism of MOODREAL® in a serotonin uptake assay on rat synaptosomes to evaluate SSRI activity.
- The experiment was chosen because in vitro tests on rat synaptosomes are the reference to validate Selective Serotonin Re-uptake Inhibitor (SSRI) activity.
- Imipramine was chosen as the standard since it is a SSRI, and it is used as the reference compound to inhibit 100% of serotonin re-uptake.
Study Results

- MOODREAL® at a concentration of 3 mg/mL demonstrated an inhibition of serotonin re-uptake equivalent to 67% of the inhibition caused by Imipramine (TOFRANIL®) at 10 mg/mL, a “golden standard” selective serotonin reuptake inhibitor (SSRI).
- The >50% Serotonin re-uptake in this test demonstrates a significant effect of SSRI in this validated model to test antidepressant medication effects.
- Thus, this study demonstrates the significant activity of MOODREAL® in an in vitro study even when compared to antidepressant medication.

Substantial Equivalence
Imipramine vs Saffron
Fluoxetine vs Saffron
Placebo vs Saffron
Imipramine vs Saffron
Clinical Trial (double blind, randomised)
Parameters
- 30 adults
- 6 weeks
- Hamilton Depression scoring > 18
Groups
- A: 10 mgX3/d saffron ext.>2% safranal
- B: 100 mg/d Imipramine
Results
- As efficient as Imipramine (TOFRANIL®) (***p<0.001)
Fluoxetine vs Saffron
Clinical Trial (double blind, randomised)
Parameters
- 40 adults
- 6 weeks
- Hamilton Depression scoring > 18
Groups
- A: 15mgX2/d saffron ext.>2% safranal
- B: 20 mg/d Fluoxetine
Results
- As efficient as Fluoxetine (PROZAC®) (***p<0.001)
Placebo vs Saffron
Clinical Trial (double blind, randomised)
Parameters
- 40 adults
- 6 weeks
- Hamilton Depression scoring > 18
Groups
- A: 15mgX2/d saffron ext.>2% safranal
- B: placebo
Results
- More efficient than placebo (***p<0.001)
Applications

Functional foods

Bars

Shakes

Beverages

Confectionary

Powders

Snacks diet products

Supplements

Meal replacements
Request a quote and sample
Would you like to request an estimate or samples of our products? Send us your request on this simple form and our team will get in touch with you to answer any questions you might have and to find out more about your needs.
Fields with (*) are required
"*" indicates required fields











